Details of the Drug Formulations

General Information of Drug (ID: DM4K7GQ)

Drug Name
Erythromycin Drug Info
Synonyms
Abboticin; Abomacetin; Acneryne; Acnesol; Aknemycin; Aknin; AustriaS; Benzamycin; Derimer; Deripil; Dotycin; Dumotrycin; ERY; ERYC; Emgel; Emuvin; Emycin; Endoeritrin; Erecin; Erisone; Eritomicina; Eritrocina; Eritromicina; Ermycin; Eros; Eryacne; Eryacnen; Erycen; Erycette; Erycin; Erycinum; Eryderm; Erydermer; Erygel; Eryhexal; Erymax; Erymed; Erysafe; Erytab; Erythro; Erythroderm; Erythrogran; Erythroguent; Erythromid; Erythromycine; Erythromycinum; Erytop; Erytrociclin; Ilocaps; Iloticina; Ilotycin; Inderm; IndermRetcin; Latotryd; Lederpax; Mephamycin; Mercina; Oftamolets; Paediathrocin; Pantoderm; Pantodrin; Pantomicina; Pharyngocin; Primacine; Propiocine; Proterytrin; Retcin; Robimycin; Romycin; Sansac; Staticin; Stiemicyn; Stiemycin; Tiloryth; Tiprocin; Torlamicina; Wemid; Akne Cordes Losung; Aknederm Ery Gel; Benzamycin Pak; ERYTHROMYCIN STEARATE; Eryc Sprinkles; Erythromycin A; Erythromycin Lactate; Erythromycin Ointment; Erythromycin base; Erythromycin intravenous; Erythromycin sodium lauryl sulfate; Inderm Gel; Oftalmolosa Cusi Eritromicina; Skid Gel E; Theramycin Z; Udima Ery Gel; E0751; Eryc 125; Erythromast 36; Ak-Mycin; Akne-Mycin; Del-Mycin; E-Base; E-Glades; E-Mycin; E-Solve 2; ERYC (base); Emu-V; Emu-Ve; Erimycin-T; Eritromicina [INN-Spanish]; Ery-B; Ery-Diolan; Ery-Sol; Ery-Tab; Ery-maxin; Eryc (TN); Eryc-125; Eryc-250; Erygel (TN); Erythra-Derm; Erythro-Statin; Erythro-Teva; Erythromycin & VRC3375; Erythromycine [INN-French]; Erythromycinum [INN-Latin]; Ilosone (TN); Ilosone (estolate); Ilotycin T.S; Kesso-Mycin; N-Methylerythromycin A; PCE Dispertab (base); Pce (TN); R-P Mycin; Sans-acne; Staticin (TN); T-Stat; Taimoxin-F; A/T/S; Akne-mycin (TN); C-Solve-2; E-Base (base); E-Mycin (base); Ery-Tab (base); Erythromycin [INN:BAN:JAN]; Ilotycin T.S.; T-stat (TN); E-mycin, Erycin, Robimysin; Erythromycin (JP15/USP/INN); Erythromycin, compd. with monododecyl sulfate, sodium salt; Sulfuric acid, monododecyl ester, sodium salt, compd. with erythromycin; Adecane-2,10-dione (non-preferred name); Erythromycin A, T-Stat, Pantomicina, HSDB 3074, Erytab, DRG-0279; Ery
Indication
Disease Entry ICD 11 Status REF
Acne vulgaris ED80 Approved [1]
Acute gonococcal cervicitis Approved [1]
Acute otitis media AB00 Approved [1]
Bacteremia 1A73 Approved [1]
Bacterial infection 1A00-1C4Z Approved [2]
Cholangitis Approved [1]
Gastroparesis DA41.00 Approved [1]
Hepatic coma Approved [1]
Inclusion conjunctivitis Approved [1]
Legionnaires' disease Approved [1]
Listeriosis Approved [1]
Mycoplasma pneumoniae pneumonia Approved [1]
Preterm premature rupture of the membranes Approved [1]
Staphylococcus aureus infection Approved [1]
Streptococcal pneumonia Approved [1]
Syphilis Approved [1]
Urinary tract infection GC08 Approved [1]
Erythema ME64.0 Investigative [1]
Pneumonia caused by chlamydia Investigative [1]
Therapeutic Class
Antibiotics
Cross-matching ID
PubChem CID
12560
ChEBI ID
CHEBI:42355
CAS Number
114-07-8
TTD ID
D02YIZ
VARIDT ID
DR00050
INTEDE ID
DR0614
ACDINA ID
D00241

Full List of Drug Formulations Containing This Drug

Erythromycin 250 mg tablet
Company Formulation ID FDA Description
Physicians Total Care; Rebel Distributors F07360 Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycol
AbbVie; Arbor Pharmaceuticals; Avera McKennan Hospital; PD-Rx Pharmaceuticals F07359 Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Polyethylene glycols; Povidones
A-S Medication Solutions F07364 Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols; Povidones
RemedyRepack F07365 Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols; Povidones
RemedyRepack F07361 Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Aluminum oxide; Cellulose, microcrystalline; Colloidal silicon dioxide; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols; Povidones
A-S Medication Solutions; Carilion Materials Management F07363 Sorbitan monooleate; D&c red no. 30; Sodium citrate, unspecified form; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Silicon dioxide; Aluminum oxide; Crospovidone (15 mpa.s at 5%); Hydroxypropyl cellulose (1200000 mw); Hypromellose phthalate (24% phthalate, 55 cst); Hypromellose, unspecified; Microcrystalline cellulose; Polyethylene glycol, unspecified; Povidone, unspecified
A-S Medication Solutions; Carilion Materials Management F07357 Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Diacetylated monoglycerides; Hydroxypropyl cellulose (type h); Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Povidones
Stat Rx USA F07362 Sorbitan monooleate; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Cellulose, microcrystalline; Colloidal silicon dioxide; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycol
Arbor Pharmaceuticals F07358 Sorbitan monooleate; Sodium citrate, unspecified form; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Diacetylated monoglycerides; Hydroxypropyl cellulose (1200000 mw); Hypromellose phthalate (24% phthalate, 55 cst); Hypromellose, unspecified; Microcrystalline cellulose; Povidone, unspecified
Kaiser Foundation Hospitals; PD-Rx Pharmaceuticals F07385 Sorbitan monooleate; Sodium citrate; D&c red no. 7; Sorbic acid; Propylene glycol; Titanium dioxide; Carboxymethylcellulose sodium; Povidone; Polacrilin potassium; Polyethylene glycols; Powdered cellulose; Starch, corn
A-S Medication Solutions; Arbor Pharmaceuticals; RemedyRepack F07386 Sorbitan monooleate; Sodium citrate; D&c red no. 7; Sorbic acid; Propylene glycol; Titanium dioxide; Carboxymethylcellulose sodium; Polacrilin potassium; Polyethylene glycols; Povidones; Powdered cellulose; Starch, corn
A-S Medication Solutions F07389 Sorbitan monooleate; Sodium citrate, unspecified form; D&c red no. 7; Sorbic acid; Propylene glycol; Titanium dioxide; Carboxymethylcellulose sodium, unspecified form; Polacrilin potassium; Polyethylene glycol, unspecified; Povidone, unspecified; Powdered cellulose; Starch, corn
Blenheim Phamacal F07388 Sorbitan monooleate; Sodium citrate; D&c red no. 7; Sorbic acid; Titanium dioxide; Carboxymethylcellulose sodium; Polacrilin potassium; Polyethylene glycols; Povidones; Starch, corn
RemedyRepack F07387 Sorbitan monooleate; Sodium citrate; D&c red no. 7; Propylene glycol 1,2-distearate; Sorbic acid; Titanium dioxide; Carboxymethylcellulose sodium (0.7 carboxymethyl substitution per saccharide 100-200 mpa.s at 1%); Polacrilin potassium; Polyethylene glycols; Povidones; Powdered cellulose; Starch, corn
------------------------------------------------------------------------------------
⏷ Show the Full List of 14 Formulation(s)
Erythromycin 500 mg tablet
Company Formulation ID FDA Description
Lake Eire Medical & Surgical Supply DBA Quality Care Products; Physicians Total Care; Rebel Distributors F07379 Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycol
Cardinal Health F07380 Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromellose 2208 (100 mpa.s); Hypromelloses; Polyethylene glycol
AbbVie; Arbor Pharmaceuticals; PD-Rx Pharmaceuticals; RemedyRepack F07378 Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Polyethylene glycols; Povidones
A-S Medication Solutions; Lake Eire Medical & Surgical Supply DBA Quality Care Products F07381 Sorbitan monooleate; D&c red no. 30; Sodium citrate; Magnesium stearate; Sorbic acid; Propylene glycol; Sodium hydroxide; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Aluminum oxide; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h); Hypromelloses; Polyethylene glycols; Povidones
A-S Medication Solutions; PD-Rx Pharmaceuticals; RemedyRepack F07374 Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Diacetylated monoglycerides; Hydroxypropyl cellulose (type h); Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Povidones
Physicians Total Care F07375 Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Cellulose, microcrystalline; Colloidal silicon dioxide; Hydroxypropyl cellulose; Hypromelloses
Arbor Pharmaceuticals F07376 Sorbitan monooleate; Sodium citrate, unspecified form; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Diacetylated monoglycerides; Hydroxypropyl cellulose (1200000 mw); Hypromellose phthalate (24% phthalate, 55 cst); Hypromellose, unspecified; Microcrystalline cellulose; Povidone, unspecified
Arbor Pharmaceuticals F07377 Stearic acid; Vanillin; Citric acid monohydrate; Propylene glycol; Talc; Titanium dioxide; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Polyethylene glycols; Povidones; Powdered cellulose
RemedyRepack F07390 Vanillin; Sorbitan monooleate; Magnesium hydroxide; Propylene glycol; Titanium dioxide; Fd&c red no. 3; Povidone; Polacrilin potassium; Starch, corn
Blenheim Phamacal F07391 Vanillin; Sorbitan monooleate; Magnesium hydroxide; Propylene glycol; Titanium dioxide; Fd&c red no. 3; Polacrilin potassium; Povidones; Starch, corn
------------------------------------------------------------------------------------
⏷ Show the Full List of 10 Formulation(s)
Erythromycin 333 mg tablet
Company Formulation ID FDA Description
Kaiser Foundation Hospitals F07369 Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Hypromellose; Povidone; Silicon dioxide; Caprylic/capric mono/diglycerides; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromellose 2208 (15000 cps)
RemedyRepack F07370 Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Silicon dioxide; Caprylic/capric mono/diglycerides; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromellose 2208 (15000 mpa.s); Hypromelloses
Rebel Distributors F07371 Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses
Stat Rx USA F07373 Sorbitan monooleate; Sodium citrate; Magnesium stearate; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Silicon dioxide; Cellulose, microcrystalline; Diacetylated monoglycerides; Hydroxypropyl cellulose; Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses
A-S Medication Solutions; Carilion Materials Management; PD-Rx Pharmaceuticals F07367 Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Silicon dioxide; Cellulose, microcrystalline; Diacetylated monoglycerides; Hydroxypropyl cellulose (type h); Hypromellose phthalate (24% phthalate, 55 cst); Hypromelloses; Povidones
Physicians Total Care F07368 Sorbitan monooleate; Sodium citrate; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Crospovidone; Povidone; Cellulose, microcrystalline; Colloidal silicon dioxide; Hydroxypropyl cellulose; Hypromelloses
Arbor Pharmaceuticals F07372 Stearic acid; Vanillin; Lactose; D&c red no. 30; Magnesium stearate; Citric acid monohydrate; Propylene glycol; Silicon dioxide; Cellulose, microcrystalline; Povidones; Powdered cellulose; Sodium starch glycolate type a corn
A-S Medication Solutions; Arbor Pharmaceuticals; PD-Rx Pharmaceuticals F07366 Sorbitan monooleate; Sodium citrate, unspecified form; Magnesium stearate; Ammonia; Propylene glycol; Talc; Titanium dioxide; Croscarmellose sodium; Silicon dioxide; Crospovidone (15 mpa.s at 5%); Diacetylated monoglycerides; Hydroxypropyl cellulose (1200000 mw); Hypromellose phthalate (24% phthalate, 55 cst); Hypromellose, unspecified; Microcrystalline cellulose; Povidone, unspecified
------------------------------------------------------------------------------------
⏷ Show the Full List of 8 Formulation(s)
Erythromycin 400 mg tablet
Company Formulation ID FDA Description
Arbor Pharmaceuticals F07383 D&c red no. 30; D&c yellow no. 10; Fd&c red no. 40; Sodium citrate, unspecified form; Magnesium stearate; Sorbic acid; Propylene glycol; Sucrose; Titanium dioxide; Polacrilin potassium; Polyethylene glycol, unspecified; Powdered cellulose; Starch, corn
PD-Rx Pharmaceuticals F07382 Citric acid; Sodium citrate; Magnesium aluminum silicate; Sucrose; Carboxymethylcellulose sodium; Fd&c red no. 3
Physicians Total Care F07384 Fd&c red no. 40; Sodium citrate; Magnesium stearate; Sucrose; Polacrilin potassium; Starch, corn
------------------------------------------------------------------------------------
Erythromycin 250 mg capsule
Company Formulation ID FDA Description
Kaiser Foundation Hospitals F07355 D&c red no. 30; D&c yellow no. 10; Fd&c blue no. 1; Magnesium stearate; Citric acid monohydrate; Titanium dioxide; Fd&c red no. 3; Povidone; Gelatin; Powdered cellulose
Stat Rx USA F07353 D&c red no. 30; D&c yellow no. 10; Fd&c blue no. 1; Magnesium stearate; Titanium dioxide; Fd&c red no. 3; Povidone; Gelatin
A-S Medication Solutions; Arbor Pharmaceuticals F07356 D&c red no. 30; D&c yellow no. 10; Fd&c blue no. 1; Magnesium stearate; Citric acid monohydrate; Titanium dioxide; Fd&c red no. 3; Gelatin; Povidones; Powdered cellulose
Mayne Pharma F07354 Lactose, unspecified form; Fd&c yellow no. 6; Titanium dioxide; Gelatin, unspecified; Povidone, unspecified
------------------------------------------------------------------------------------

References

1 Erythromycin FDA Label
2 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 1456).